1 Cash Cow with Massive Upside
CVS Health (NYSE:CVS) share price declined by over 23% over the past twelve months. Hurting shareholders was the recent leadership transition from CEO Karen Lynch to David Joyner, a shift that brought uncertainty to the company’s direction as investors questioned the company’s stability while facing ongoing challenges. » Read more about: 1 Cash Cow with Massive Upside »
Read More
Insights: 1 Super Safe Stock Can Turn $100,000 into $250k by 2030
It’s been a bumpy ride for the stock market over the past year yet one stock has largely bucked the trend: Berkshire Hathaway.
In 2022, the share price of Buffett’s company rose by just 4% compared to the S&P 500, which declined by 18.11%. From 1965 to 2022, Berkshire had a compounded annual gain of 19.8% compared to 9.9% for the S&P 500.
» Read more about: Insights: 1 Super Safe Stock Can Turn $100,000 into $250k by 2030 »
Read More
Insights: Man With Perfect Track Record Bets BIG On 1 Latin Stock
Some investors grab all the headlines. And there there are the few extraordinary investors who keep a low profile but are well worth keeping a close eye on. Stanley Druckenmiller fits into that second group.
He’s famously never had a down year thanks in part to rigorous adherence to disciplined risk management. He has also got a really good track record of picking winners.
» Read more about: Insights: Man With Perfect Track Record Bets BIG On 1 Latin Stock »
Read More
1 Monster Stock To Buy With No Hesitation
If you’re going to throw down your money on a stock right now with no hesitation, you’ll want to be sure it’s a money-maker. The first thing it must possess is a wide economic moat that ensures competition or capital can’t dethrone it. Here’s a quick flashback in time to highlight what we mean.
A few decades ago,
» Read more about: 1 Monster Stock To Buy With No Hesitation »
Read More
Billionaire Bets on Fast Growth Unit In Boring Stock
If you only look at consumer trends within the United States, it might seem odd that Philip Morris’s stock has done so well. Aren’t people giving up cigarettes?
For the most part, they are, but the company has planned for the effects of smoking cessation programs. The share price speaks to Philip Morris’s success.
» Read more about: Billionaire Bets on Fast Growth Unit In Boring Stock »
Read MoreThe Burst
Is Lemonade Stock a Sweet Deal Down 87%
When insurance technology firm Lemonade first debuted on the markets at an official price of $29 before soaring to $66 per share, it was caught up in a frenzy of bullish speculation that subsequently led the stock to rally to $183 per share.
But the excitement wasn’t to last and now the share price sits about 85% lower.
» Read more about: Is Lemonade Stock a Sweet Deal Down 87% »
Read MoreThe Spotlight
1 Indicator Has Been Right for 77 Years: What’s It Saying Now
Imagine having access to an indicator that has reliably predicted recessions with high accuracy for almost a century. Surprisingly, there is an indicator that has done just that, without receiving much mainstream attention.
This indicator was recently tallied at the end of February, so what does it say? Interestingly, the indicator’s reading contradicts the predictions of other signals that suggest a lingering bear market.
» Read more about: 1 Indicator Has Been Right for 77 Years: What’s It Saying Now »
Read MoreThe Daily
Dow Jones Top Company Headlines at 11 AM ET: Nvidia Invests $2 Billion in CoreWeave in AI-Factory Collaboration | Quantum-Computing …
Nvidia Invests $2 Billion in CoreWeave in AI-Factory Collaboration
The companies said they would build AI factories on Nvidia’s computing-platform technology.
—-
Quantum-Computing Company IonQ to Buy Chip Maker SkyWater for $1.8 Billion
IonQ works with the U.S. government and has been on a deal spree.